HK1150859A1 - Method of extracting virus from cell culture - Google Patents

Method of extracting virus from cell culture

Info

Publication number
HK1150859A1
HK1150859A1 HK11104931.1A HK11104931A HK1150859A1 HK 1150859 A1 HK1150859 A1 HK 1150859A1 HK 11104931 A HK11104931 A HK 11104931A HK 1150859 A1 HK1150859 A1 HK 1150859A1
Authority
HK
Hong Kong
Prior art keywords
cell culture
extracting virus
virus
extracting
culture
Prior art date
Application number
HK11104931.1A
Other languages
English (en)
Chinese (zh)
Inventor
Matthew Coffey
Bradley Thompson
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of HK1150859A1 publication Critical patent/HK1150859A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/765—Reovirus; Rotavirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12251—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK11104931.1A 2001-03-16 2004-06-10 Method of extracting virus from cell culture HK1150859A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27673401P 2001-03-16 2001-03-16

Publications (1)

Publication Number Publication Date
HK1150859A1 true HK1150859A1 (en) 2012-01-13

Family

ID=29420186

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11104931.1A HK1150859A1 (en) 2001-03-16 2004-06-10 Method of extracting virus from cell culture

Country Status (14)

Country Link
US (2) US6808916B2 (da)
EP (2) EP2253701B1 (da)
JP (2) JP4087712B2 (da)
AR (1) AR034216A1 (da)
BR (1) BR0207527A (da)
CA (1) CA2437962C (da)
DK (1) DK2253701T3 (da)
ES (1) ES2500645T3 (da)
HK (1) HK1150859A1 (da)
IL (2) IL157304A0 (da)
MX (1) MXPA03007535A (da)
NZ (1) NZ527525A (da)
WO (1) WO2002074940A1 (da)
ZA (1) ZA200306228B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0309659A (pt) * 2002-04-30 2005-02-22 Oncolytics Biotech Inc Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
CN1806040A (zh) * 2003-06-10 2006-07-19 株式会社岛津制作所 哺乳动物培养细胞提取液和其调制方法以及使用了该提取液的无细胞系蛋白质合成方法
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
CA2617600A1 (en) 2005-08-01 2007-09-07 University Technologies International, Inc. Attenuated reovirus
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
EP2132315B1 (en) 2007-03-12 2015-07-15 Oncolytics Biotech Inc. Reoviruses having modified sequences
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
TW200909581A (en) * 2007-05-21 2009-03-01 Oncolytics Biotech Inc Mutant reoviruses and methods of making and using
WO2009052617A1 (en) * 2007-10-22 2009-04-30 Oncolytics Biotech Inc. Treatment regime for proliferative disorders
CN201163385Y (zh) * 2008-01-15 2008-12-10 昆山渝榕电子有限公司 笔记本电脑及其脚垫
MX2010012857A (es) * 2008-05-27 2010-12-20 Oncolytics Biotech Inc Supresion de produccion de citoquina proinflamatoria durante la terapia de reovirus oncolitico.
JP2011520993A (ja) * 2008-05-27 2011-07-21 オンコリティクス バイオテク，インコーポレーテッド 間質圧力の調節並びに腫瘍崩壊性ウイルスの送達及び分布
SG190418A1 (en) 2010-12-02 2013-07-31 Oncolytics Biotech Inc Liquid viral formulations
ES2630012T3 (es) 2010-12-02 2017-08-17 Oncolytics Biotech Inc. Formulaciones virales liofilizadas
DK2702147T3 (da) 2011-04-29 2020-09-28 Oncolytics Biotech Inc Fremgangsmåder til oprensning af vira ved hjælp af gelpermeationskromatografi
CA2906593C (en) * 2013-03-15 2022-11-15 Ansun Biopharma, Inc. Method of protein purification
US20160271193A1 (en) 2013-11-15 2016-09-22 Oncolytics Biotech Inc. Oncolytic viruses and increased cancer treatment regimens
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
WO2016130569A1 (en) * 2015-02-09 2016-08-18 Mj Biologics, Inc. A composition comprising pedv antigens and methods for making and using the composition
BR112017001177B1 (pt) 2014-07-24 2022-05-24 Janssen Vaccines & Prevention B.V Método de purificação e de potenciação da liberação de poliovírus a partir de uma colheita de cultura celular bruta contendo poliovírus e uso de um detergente catiônico
GB201417042D0 (en) * 2014-09-29 2014-11-12 Fkd Therapies Oy Method
WO2023277173A1 (ja) * 2021-06-30 2023-01-05 旭化成メディカル株式会社 ウイルスの回収方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja) 1986-08-11 1988-02-25 Biseibutsu Kagaku Kenkyusho:Kk 豚のレオウイルス感染症ワクチン
US5614413A (en) * 1993-07-01 1997-03-25 The Uab Research Foundation Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
ATE348155T1 (de) * 1996-11-20 2007-01-15 Introgen Therapeutics Inc Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
US6214333B1 (en) * 1997-07-08 2001-04-10 Texas Heart Institute Vasoprotective recombinant adenovirus vector containing a human TFPI gene
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
TWI289158B (en) * 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus

Also Published As

Publication number Publication date
DK2253701T3 (da) 2014-10-20
CA2437962A1 (en) 2002-09-26
WO2002074940A1 (en) 2002-09-26
EP2253701B1 (en) 2014-08-13
CA2437962C (en) 2005-11-15
IL157304A (en) 2010-04-29
AR034216A1 (es) 2004-02-04
US6808916B2 (en) 2004-10-26
EP2253701A1 (en) 2010-11-24
ES2500645T3 (es) 2014-09-30
US7186542B2 (en) 2007-03-06
US20020168764A1 (en) 2002-11-14
IL157304A0 (en) 2004-02-19
JP2007295937A (ja) 2007-11-15
US20050095692A1 (en) 2005-05-05
NZ527525A (en) 2005-03-24
BR0207527A (pt) 2004-02-25
ZA200306228B (en) 2004-08-12
JP4087712B2 (ja) 2008-05-21
JP2004520841A (ja) 2004-07-15
MXPA03007535A (es) 2003-12-11
EP1370643A1 (en) 2003-12-17

Similar Documents

Publication Publication Date Title
IL157304A0 (en) Method of extracting virus from cell culture
IL161858A0 (en) Cell culture process
EP1434887A4 (en) METHOD OF ISOLATING CELLS AND USE THEREOF
AU2001234608A1 (en) Methods for analysis of gene expression
IL153906A0 (en) Method for direct genetic analysis of target cells
HUP0500161A3 (en) Methods to culture circovirus
EP1489416A4 (en) METHOD FOR THE EVALUATION OF VIRUS INFECTION
EP1447091A4 (en) NEW METHOD FOR INDUCTION OF ANTIGEN SPECIFIC T CELLS
EP1625832A4 (en) PROCESS FOR REMOVING CELLS
AU2003232781A1 (en) Method for nucleic acid extraction and nucleic acid purification
AU2003302701A8 (en) Method of dynamically culturing embryonic stem cells
HUP0402337A3 (en) Method for the recovery and purification of poxviruses from infected cells
IL158927A (en) Method for virus propagation
EP1382673A4 (en) METHOD FOR THE CULTURE OF TAKEN BIOPSY CELLS
EP1394109A4 (en) METHOD FOR SEPARATING ACID
GB0416516D0 (en) Method of transducing es cells
AU2261802A (en) Method of analyzing gene expression
AU2002222618A1 (en) Method of analyzing gene expression
EP1432822A4 (en) METHOD FOR RECOVERING AND ANALYZING A CELLULAR COMPONENT OF CULTIVATED CELLS WITHOUT NEED TO HARVES CELLS FIRST
IL161066A0 (en) Method for preparing heparin from mast cell cultures
AU2003270814A8 (en) Method of extracting nucleic acids from microbial samples
TWI318643B (en) Method of extracting virus from cell culture
EP1378569A4 (en) METHOD FOR EXTRACTING VIRAL GENES AND EXTRACTION APPARATUS
EG25192A (en) Method of extracting iron-oxides.
AU2003208649A1 (en) Method of extracting, isolating and purifying sesame protein

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220310